The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content


Top links: Canadian bank named world’s second strongest

A roundup of what The Globe and Mail's market strategist Scott Barlow is reading this morning on the World Wide Web.

The management team at Valeant Pharmaceuticals International Inc. have clearly had enough of the growing skepticism about the health of the balance sheet and the sustainability of its growth strategy. The company announced a press conference for June 17 that it says will “refute recent misleading assertions made by Allergan, Inc. and others.”